We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Pitney Bowes
PBI
$2.27B
| $992K | ﹤0.01% |
273,990
+196,808
| +255% | +$897K |
|
1427
Paylocity
PCTY
$7.7B
| $990K | ﹤0.01% |
5,720
-14,277
| -71% | -$2.6M |
|
|
B
1428
DELISTED
Barnes Group Inc.
B
| $984K | ﹤0.01% |
31,598
+22,739
| +257% | +$792K |
|
1429
Peapack-Gladstone Financial
PGC
$806M
| $982K | ﹤0.01% |
33,065
-1,391
| -4% | -$44.5K |
|
1430
Andersons Inc
ANDE
$2.18B
| $981K | ﹤0.01% |
29,737
+7,367
| +33% | +$313K |
|
|
DEN
1431
DELISTED
Denbury Inc.
DEN
| $980K | ﹤0.01% |
16,340
-1,403
| -8% | -$99.7K |
|
1432
Bloomin' Brands
BLMN
$952M
| $979K | ﹤0.01% |
58,913
+332
| +0.6% | +$6.74K |
|
1433
Itron
ITRI
$4.52B
| $979K | ﹤0.01% |
19,806
-7,156
| -27% | -$355K |
|
1434
Rambus
RMBS
$10.5B
| $979K | ﹤0.01% |
45,539
+1,588
| +4% | +$39.3K |
|
|
CVET
1435
DELISTED
Covetrus, Inc. Common Stock
CVET
| $978K | ﹤0.01% |
47,121
-47,636
| -50% | -$848K |
|
1436
Leslie's
LESL
$12.4M
| $975K | ﹤0.01% |
3,293
+1,470
| +81% | +$549K |
|
1437
Williams Companies
WMB
$88.4B
| $972K | ﹤0.01% |
31,143
-62,256
| -67% | -$2.15M |
|
1438
Ryman Hospitality Properties
RHP
$7.7B
| $969K | ﹤0.01% |
12,744
+2,808
| +28% | +$248K |
|
1439
Spire
SR
$4.87B
| $964K | ﹤0.01% |
13,015
+5,788
| +80% | +$435K |
|
1440
Matthews International
MATW
$733M
| $963K | ﹤0.01% |
33,580
+2,110
| +7% | +$64.5K |
|
1441
Essential Properties Realty Trust
EPRT
$6.5B
| $959K | ﹤0.01% |
44,641
-5,702
| -11% | -$133K |
|
1442
Ribbon Communications
RBBN
$356M
| $959K | ﹤0.01% |
315,429
+87,987
| +39% | +$266K |
|
1443
CRA International
CRAI
$1.06B
| $956K | ﹤0.01% |
10,699
-3,110
| -23% | -$261K |
|
1444
Carvana
CVNA
$79.2B
| $956K | ﹤0.01% |
+218,045
| New | +$2.29M |
|
1445
Broadstone Net Lease
BNL
$3.96B
| $954K | ﹤0.01% |
46,522
-43,185
| -48% | -$903K |
|
1446
Constellium
CSTM
$4.05B
| $954K | ﹤0.01% |
72,189
-64,044
| -47% | -$1.02M |
|
1447
Griffon
GFF
$4.84B
| $948K | ﹤0.01% |
33,816
-73,032
| -68% | -$1.84M |
|
1448
The Ensign Group
ENSG
$10.5B
| $941K | ﹤0.01% |
12,809
+365
| +3% | +$29.1K |
|
|
GCP
1449
DELISTED
GCP Applied Technologies Inc.
GCP
| $940K | ﹤0.01% |
30,045
-11,265
| -27% | -$351K |
|
1450
Insulet
PODD
$10B
| $936K | ﹤0.01% |
4,343
-1,825
| -30% | -$415K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.